Ticker LaunchIPO · DTIL
Precision Biosciences Inc
Precision Biosciences Inc (DTIL) priced its initial public offering on Mar 28, 2019 at $16.00 per share, within its $15.00–$17.00 range, raising $126.4M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $784.5M. Cooley advised the underwriters.
- Status
- IPO
- Ticker
- DTIL
- Exchange
- Nasdaq Global Select
- Priced
- Mar 28, 2019
- IPO price
- $16.00
- Price range
- $15.00–$17.00
- Raised
- $126.4M
- Market cap at IPO price
- $784.5M
- First filed
- Mar 1, 2019
- Underwriters' counsel
- Cooley
- Sector
- Biotech & pharma
- Country / state
- NC
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Mar 1, 2019
- Latest amendment Mar 18, 2019
- Final prospectus (424B4) Mar 28, 2019
- All filings on EDGAR CIK 1357874
Other Biotech & pharma IPOs in 2019
- HOOKIPA Pharma Inc.HOOK · Apr 19, 2019 · $84M
- Turning Point Therapeutics, Inc.TPTX · Apr 18, 2019 · $166.5M
- NGM Biopharmaceuticals IncNGM · Apr 4, 2019 · $106.7M
- Genfit S.A.GNFT · Mar 27, 2019 · $135.1M
- Kaleido Biosciences, Inc.KLDO · Mar 1, 2019 · $75M
- Stealth BioTherapeutics CorpMITO · Feb 15, 2019 · $78M